Clinical Trials Directory

Trials / Unknown

UnknownNCT05457088

High Protein Effect on Body Composition and Sarcopenia Markers in Older Patients With Type 2 Diabetes Mellitus

The Effect of High Protein on Body Composition and Markers of Sarcopenia in Patients With Type 2 Diabetes Mellitus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
National and Kapodistrian University of Athens · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the impact of dietary protein intake on progressive muscle loss and functionality (sarcopenia) in older adults with type 2 diabetes mellitus. Sarcopenia is known to have a bidirectional interaction with type 2 diabetes mellitus. Therefore in order to address this bidirectional complication we suggest that an increased intake of dietary protein at 1.5 gr/kg/day (current official recommendation is 0.8 gr/kg/day) could help to treat the sarcopenia, which in turn will help to ameliorate the type 2 diabetes mellitus progression.

Conditions

Interventions

TypeNameDescription
OTHER1.5 proteindietary plan having dietary protein of 1.5 gr/kg/day
OTHER0.8 proteindietary plan having dietary protein of 0.8 gr/kg/day

Timeline

Start date
2021-11-01
Primary completion
2022-10-31
Completion
2022-10-31
First posted
2022-07-13
Last updated
2022-07-13

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05457088. Inclusion in this directory is not an endorsement.